Search
for
Sort by
Research 721–750 of 1000+
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- 5α-Reductase inhibitors in androgenetic alopecia
- The rationale for physiological testosterone replacement in women
- Hidradenitis Suppurativa
- Hirsutism: diagnosis and treatment
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Stem cells and aberrant signaling of molecular systems in skin aging
- Male hormonal contraception: looking back and moving forward
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Secondary cicatricial and other permanent alopecias
- Systemic causes of hair loss
- Primary Cicatricial Alopecias
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles
- Diabetex: A novel approach for diabetic wound healing
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Targets to treat androgen excess in polycystic ovary syndrome
- Hirsutism
- Multiple minute digitate hyperkeratosis
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Dermatological problems of asylum seekers arriving on boats: A case report from Australia and a brief review
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Recent therapeutic developments for acne
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Ottawa, Ontario, Canada, February 13–16, 2013
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Debatable Topics in PCOS Patients